Tagged with PR

Spain The global acquisition of GSK’s thrombosis portfolio and subsequent purchase of AstraZeneca’s anaesthesia business have been critical milestones for the maverick South African pharmaceutical outfit Aspen, enabling the company to establish a consolidated presence across Europe, including the opening of the firm’s first-ever Spanish affiliate only two and a half…

Spain Perhaps the only CEO of a dermo-cosmetics company with a PhD in astrophysics and space technology as well as three years working at NASA under his belt, Isdin’s Juan Naya feels he is uniquely positioned to lead a firm creating products that protect against the sun’s rays.   It was…

Puerto Rico Iris and Tom Vincent, president and vice president of Prime Air Corp, discuss how the pharma and medical devices logistics company is growing by more than 20 percent per year through a highly customer-centric offer, which has also improved the business continuity plans of its clients. Currently constructing the island’s…

USA In a bid to make tangible progress on the issue of lowering prescription drug pricing before the 2020 presidential election, the Trump administration is planning to import cheaper medicines from Canada and elsewhere. However, as the Eurasia Group’s Aditya Bhattacharji and Sandra Yamin Namoos outline, the proposed plan’s impact on…

Pricing Generic drugs foster competition in the pharmaceutical market. Chester “Chip” Davis, Jr.  of the Association for Accessible Medicines (AAM) reveals the data behind generic competition and elaborates on opportunities for further savings.    The American public is clamoring for systemic changes to address skyrocketing drug prices. Specialty drugs—a growing category…

Puerto Rico Manuel Laboy Rivera, Secretary of the Department of Economic Development and Commerce (DEDC) and Executive Director of the Puerto Rico Industrial Development Company (PRIDCO) is discussing Puerto Rico’s integrated economic development plan, which aims to retain and expand current investment by the industry, while also attracting new companies to the…

Puerto Rico Dr Agustín Rullán, the newly appointed chancellor of the University of Puerto Rico Mayagüez (UPRM) and former dean of the university’s College of Engineering, outlines the main priorities in his new position. He highlights the need for strong collaboration between academia and industry and the progress UPRM has made working…

China HE Ming, founder and CEO of Sino-American (Suzhou) Pharmaceutical Services (SAPS), shares his commitment to bringing international quality standards to the Chinese pharma industry, the comprehensive portfolio of quality management, verification and compliance services SAPS offers to the pharma, biotech and medical device industries in China and the US, as…

Taiwan Dr Jeffery Tzen, president of the Taiwanese Society of Molecular Medicine and precision medicine key opinion leader, offers insights into Taiwan’s adoption of the emerging field.   In order to succeed in translating precision medicine to clinical practice, quality laboratories under strong regulations must be created   What motivates you…

Puerto Rico Carlos Rodríguez, the newly elected president of the Puerto Rico Manufacturers Association (PRMA), underlines his main goal of achieving more collaboration within the association and the economic ecosystem, to facilitate lobbying efforts both in Puerto Rico and at the federal level in Washington, DC. He also highlights his aim to…

Taiwan Eric Yang, secretary general of the Taiwan Precision Medical and Molecular Diagnostics Industry Association (PMMD), speaks about the key challenges facing the sector and the top priorities of the organization and its member companies. Yang goes on to share his insights on the opportunities that exist for precision medicine and…

USA PwC’s Kelly Barnes examines how the US pharmaceutical sector is having to rethink its relationship with consumers, experimenting with new and innovative pricing models, and adopting a more holistic view of the patients using their medicines.   American consumers want more than just lower prices from pharmaceutical companies US Consumers…